The ubiquitin-proteasome pathway regulates the availability of the GH receptor

Endocrinology

Volumn 143, Issue 4, 2002, Pages 1243-1252

  Van Kerkhof, Peter ^a   Smeets, Mirjam ^b   Strous, Ger J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ARTICLE; BODY GROWTH; CARBOHYDRATE METABOLISM; ENDOCYTOSIS; GROWTH HORMONE RELEASE; HAMSTER; INTERNALIZATION; LIGAND BINDING; LYSOSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0036215093     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.4.8755     Document Type: Article

References (66)

1. The growth hormone receptor
2. Molecular mechanism of growth hormone action
3. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
4. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
5. Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription
6. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1
7. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation
8. Neuroendocrine control of growth hormone secretion
9. Turnover of growth hormone receptors in rat adipocytes
10. The mouse fibroblast growth hormone receptor: Ligand processing and receptor modulation and turnover
11. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors
12. Growth hormone-binding proteins: State of the art
13. Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation
14. Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: Relationship to GH receptor down-regulation
15. Intracellular processing of growth hormone receptors by adipocytes in primary culture
16. The ubiquitin-proteasome system and endocytosis
17. Protein regulation by monoubiquitin
18. The epidermal growth factor receptor is covalently linked to ubiquitin
19. Ligand-induced polyubiquitination of the platelet-derived growth factor β-receptor
20. Ligand-dependent polyubiquitination of c-kit gene product: A possible mechanism of receptor down regulation in M107e cells
21. Activation-induced ubiquitination of the T cell antigen receptor
22. Degradation of the met tyrosine kinase receptor by the ubiquitin-proteasome pathway
23. Growth hormone receptor and serum binding protein purification, cloning and expression
24. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
25. Down-regulation of MET, the receptor for hepatocyte growth factor
26. Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor
27. Endocytosis and degradation of the growth hormone receptor are proteasome-dependent
28. Regulation of receptor tyrosine kinase signaling by endocytic trafficking
29. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
30. Measurement of growth hormone and prolactin receptor turnover in rat liver
31. Rational design of receptor-specific variants of human growth hormone
32. A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1
33. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor
34. Growth hormone-induced signal tranduction depends on an intact ubiquitin system
35. Mechanism of membrane anchoring affects polarized expression of 2 proteins in MDCK cells
36. The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis
37. Expression of functional growth hormone receptor in a mouse L cell line infected with recombinant vaccinia virus
38. Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor
39. Identification of phenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation
40. Disulfide linkage of Growth Hormone (GH) Receptors (GHR) reflects GH- induced GHR dimerization. Association of jak2 with the ghr is enhanced by receptor dimerization
41. Growth hormone receptor internalization and signal transduction are independently regulated by the ubiquitin-system
42. Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-stat5 signaling
43. Rabbit liver growth hormone receptor and serum binding protein
44. Truncated growth hormone receptor isoforms
45. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein
46. Growth hormone-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis
47. Growth hormone induces detergent insolubility of GH receptors in IM-9 cells
48. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor
49. Receptor dimerization determines the effect of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes
50. Cellular processing of growth hormone in IM-9 cells: Evidence for exocytosis of internalized hormone
51. Conformational changes required in the human growth hormone receptor for growth hormone signaling
52. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies - A specific conformational change may be required for full-length receptor signaling
53. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
54. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor
55. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain
56. Binding and functional studies with the growth hormone receptor antagonist, b2036-peg (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer
57. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts
58. Activation of the ubiquitin pathway in rat skeletal muscle by catalytic doses of glucocorticoids
59. Increase in ubiquitin-protein conjugates concomitant with increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation
60. Sepsis stimulates non-lysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle
61. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes
62. Increased levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy
63. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway
64. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription
65. Loss of skeletal muscle in cancer: Biochemical mechanisms
66. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I